The E2F4 transcriptional cascade is suppressed upon CD4/6 inhibition in hormone independent ER+ BC cells and ER+ BC patients, thereby supporting the benefit of adjuvant CDK4/6 inhibition in ER+ patients (223). The gene discussed is E2F4; the disease is breast cancer.